inHEART Models vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

inHEART Models

by inHEART

EchoNext

by Pathway Labs

AI Verdict

These tools are adjacent in their focus on cardiology AI, but serve different stages of patient care. inHEART Models is designed for pre-procedural planning and optimization of cardiac ablation procedures using advanced 3D imaging, while EchoNext focuses on early detection of hidden structural heart disease through AI-powered ECG analysis. Therefore, inHEART is suited for interventional cardiology, while EchoNext is for diagnostic screening.

Choose inHEART Models if…

Choose inHEART Models if your primary need is highly detailed, AI-driven 3D cardiac modeling for optimizing complex image-guided cardiac ablation procedures, particularly for conditions like ventricular tachycardia. This tool excels in pre-procedural planning by providing unprecedented anatomical and scar tissue details from CT/MR images, aiming to reduce procedure times and recurrence rates.

View inHEART Models →

Choose EchoNext if…

Choose EchoNext if your goal is early and widespread screening for hidden structural heart disease using standard ECGs. This AI-powered tool is ideal for identifying patients at risk for conditions such as heart failure, valve disease, and pulmonary hypertension, especially in settings where access to more advanced imaging like echocardiography is limited.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	inHEART Models	EchoNext
Pricing	Contact for pricing	Starts at $600/month
Deployment	Cloud-based	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

inHEART Models

inHEART Models offers a straightforward interface with clean menus, logical icons, and clear tooltips, making it easy for even junior staff to use after a single walkthrough. Its browser-based access eliminates the need for thick client installation, simplifying IT management and allowing smooth case loading on standard laptops. EchoNext's usability details are not as extensively described, but its deployment through the OpenEvidence platform suggests a focus on integration within existing clinical workflows.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	inHEART Models	EchoNext
Tool Name	inHEART Models	EchoNext
Company	inHEART	Pathway Labs
Description	AI-driven software that creates detailed 3D digital twin models of the heart from CT/MR images, optimizing planning and execution of image-guided cardiac ablation procedures.	FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Features (Primary Focus)	AI-driven digital twin of the heart; Automated segmentation of CT and MR images; Highly detailed, interactive 3D cardiac models; Pre-procedural planning and optimization of treatment strategies; Seamless integration with major electroanatomic mapping (EAM) systems	AI-powered ECG analysis; Detection of hidden structural heart disease; Identifies heart failure risk; Screens for valve disease; Detects pulmonary hypertension indicators; Utilizes standard 12-lead ECGs; Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring inHEART Models and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

inHEART Models offers seamless integration with major electroanatomic mapping (EAM) systems like Cartou00ae, Rhythmiau2122, Ensiteu2122, and Afferau2122 for pre-procedural planning and intraprocedural guidance during cardiac ablation procedures. EchoNext, on the other hand, integrates with the OpenEvidence clinical decision support platform, making its AI-powered ECG analysis accessible to physicians within a platform they may already use for diagnostic support.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions?

inHEART Models aims to optimize planning and execution of cardiac ablation procedures, with early clinical evaluations showing a potential to reduce VT procedure times by 60% and recurrence rates by 38%. EchoNext has demonstrated high accuracy in detecting structural heart disease from ECGs, correctly identifying 77% of structural heart problems in a study, outperforming cardiologists who achieved 64% accuracy with non-AI-assisted reviews.

For which specialties are these tools best suited, and what is the typical learning curve for physicians?

inHEART Models is specifically designed for cardiologists and radiologists involved in image-guided cardiac ablation procedures, particularly for complex arrhythmias like ventricular tachycardia, and aims to simplify and enhance the approach to VT ablation therapy. EchoNext is suitable for a broader range of specialties including Cardiology, Family Medicine, Hospital Medicine, and Internal Medicine, as it analyzes standard ECGs for early detection of hidden structural heart disease, potentially requiring minimal additional training for interpretation of its risk flags.

What kind of support and training can physicians expect when implementing these tools?

While specific details on support quality are not provided, inHEART's mission emphasizes making world-class cardiac imaging expertise available to physicians, suggesting a focus on enabling effective use of their digital twin technology. EchoNext's partnership with OpenEvidence aims to quickly put the tool in front of doctors, implying a streamlined integration and potentially accessible support through the platform.

What are the audit-trail features of each tool, and how do they support clinical accountability?

The provided information does not explicitly detail the audit-trail features for either inHEART Models or EchoNext. However, as FDA-cleared medical devices handling patient data, both would be expected to have robust internal mechanisms for tracking data access, modifications, and algorithmic outputs to ensure clinical accountability and regulatory compliance.

What are the considerations for rolling out these tools across multiple clinical sites or a large health system?

inHEART Models is a cloud-based platform, which generally facilitates multi-site access and scalability, and the company is working to expand its presence in the US and globally. EchoNext is available through the OpenEvidence clinical decision support platform, which is used by a large number of physicians, suggesting it is designed for broad access and deployment across various clinical settings, from major hospitals to community practices.

Beyond the technical specifications, what clinical context should guide a physician's choice between these two tools?

A physician's choice should be guided by the primary clinical need: inHEART Models is ideal for electrophysiologists seeking to optimize complex cardiac ablation procedures with highly detailed 3D anatomical models for pre-procedural planning and intraprocedural guidance. EchoNext is better suited for broader screening and early detection of hidden structural heart disease from routine ECGs, particularly in primary care or general cardiology settings, to identify patients who may benefit from further diagnostic imaging like echocardiograms.